Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis
- PMID: 11079009
- DOI: 10.5858/2000-124-1599-ROHC
Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis
Abstract
Context: Cirrhosis is widely regarded as being irreversible. Recent studies have demonstrated that fibrosis may decrease with time in humans and experimental animals if the disease activity becomes quiescent. The histologic appearance of regressing cirrhosis in the human has not been described in detail.
Objectives: To define histologic parameters that indicate regression of cirrhosis and to provide an interpretation of how regression occurs from a histologic point of view.
Design: A patient who underwent a series of biopsies that showed apparent regression of hepatitis B cirrhosis is presented. In addition, 52 livers removed at transplantation having cirrhosis or incomplete septal cirrhosis were graded for histologic parameters that suggest progression or regression of fibrosis. Progression parameters were steatohepatitis, inflammation, bridging necrosis, and piecemeal necrosis. The regression parameters (collectively called the hepatic repair complex) were delicate perforated septa, isolated thick collagen fibers, delicate periportal fibrous spikes, portal tract remnants, hepatic vein remnants with prolapsed hepatocytes, hepatocytes within portal tracts or splitting septa, minute regenerative nodules, and aberrant parenchymal veins.
Results and conclusions: Regression parameters were found in all livers and were prominent in the majority. Livers with micronodular cirrhosis, macronodular cirrhosis, and incomplete septal cirrhosis demonstrate a histologic continuum. A continuum of regressive changes was also seen within individual livers. These appearances allow one to understand visually how fibrous regions of hepatic parenchyma can be returned toward a normal appearance. Many examples of incomplete septal cirrhosis could be the product of regressed cirrhosis.
Comment in
-
Controversies in pathology. Is cirrhosis of the liver a reversible disease?Arch Pathol Lab Med. 2000 Nov;124(11):1585-6; discussion 1592-3. doi: 10.5858/2000-124-1585-CIP. Arch Pathol Lab Med. 2000. PMID: 11079002 No abstract available.
-
Coming or going? What is cirrhosis?Arch Pathol Lab Med. 2000 Nov;124(11):1587-8; discussion 1592-3. doi: 10.5858/2000-124-1587-COGWIC. Arch Pathol Lab Med. 2000. PMID: 11079003 No abstract available.
-
Regression of cirrhosis. A timely topic.Arch Pathol Lab Med. 2000 Nov;124(11):1589-90; discussion 1592-3. doi: 10.5858/2000-124-1589-ROC. Arch Pathol Lab Med. 2000. PMID: 11079004 No abstract available.
-
Regression of human cirrhosis.Arch Pathol Lab Med. 2000 Nov;124(11):1591; discussion 1592-3. doi: 10.5858/2000-124-1591-ROHC. Arch Pathol Lab Med. 2000. PMID: 11079005 No abstract available.
Similar articles
-
A review of liver fibrosis and cirrhosis regression.J Pathol Transl Med. 2023 Jul;57(4):189-195. doi: 10.4132/jptm.2023.05.24. Epub 2023 Jun 20. J Pathol Transl Med. 2023. PMID: 37461143 Free PMC article. Review.
-
Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.Virchows Arch. 2018 Jul;473(1):15-22. doi: 10.1007/s00428-018-2340-2. Epub 2018 Mar 27. Virchows Arch. 2018. PMID: 29589101 Review.
-
Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis.Mod Pathol. 2020 Mar;33(3):448-455. doi: 10.1038/s41379-019-0346-1. Epub 2019 Aug 7. Mod Pathol. 2020. PMID: 31391527
-
Incomplete septal cirrhosis associated with Wegener's granulomatosis.Liver. 2002 Oct;22(5):388-93. doi: 10.1034/j.1600-0676.2002.01684.x. Liver. 2002. PMID: 12390474
-
Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis.Liver Int. 2005 Aug;25(4):817-28. doi: 10.1111/j.1478-3231.2005.01067.x. Liver Int. 2005. PMID: 15998433
Cited by
-
Update on Hepatobiliary Plasticity.Semin Liver Dis. 2023 Feb;43(1):13-23. doi: 10.1055/s-0042-1760306. Epub 2023 Feb 10. Semin Liver Dis. 2023. PMID: 36764306 Free PMC article.
-
Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection.J Clin Med. 2018 Sep 11;7(9):267. doi: 10.3390/jcm7090267. J Clin Med. 2018. PMID: 30208564 Free PMC article.
-
A review of liver fibrosis and cirrhosis regression.J Pathol Transl Med. 2023 Jul;57(4):189-195. doi: 10.4132/jptm.2023.05.24. Epub 2023 Jun 20. J Pathol Transl Med. 2023. PMID: 37461143 Free PMC article. Review.
-
Mechanisms of liver fibrosis and its role in liver cancer.Exp Biol Med (Maywood). 2020 Jan;245(2):96-108. doi: 10.1177/1535370219898141. Epub 2020 Jan 10. Exp Biol Med (Maywood). 2020. PMID: 31924111 Free PMC article. Review.
-
Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Antiviral Res. 2014 Jul;107:23-30. doi: 10.1016/j.antiviral.2014.03.012. Epub 2014 Apr 12. Antiviral Res. 2014. PMID: 24726738 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical